Stay updated on IMRT & Nivolumab for Recurrent Head & Neck Cancer Clinical Trial
Sign up to get notified when there's something new on the IMRT & Nivolumab for Recurrent Head & Neck Cancer Clinical Trial page.

Latest updates to the IMRT & Nivolumab for Recurrent Head & Neck Cancer Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check15 days agoChange DetectedThe web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference2%
- Check22 days agoNo Change Detected
- Check43 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check58 days agoChange DetectedThe webpage has undergone significant changes, including the removal of detailed descriptions of a clinical trial for recurrent head and neck squamous cell carcinoma, while adding a new registry identifier and revision number.SummaryDifference39%
- Check65 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check108 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
Stay in the know with updates to IMRT & Nivolumab for Recurrent Head & Neck Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IMRT & Nivolumab for Recurrent Head & Neck Cancer Clinical Trial page.